| Jennifer Havrilla Llc | |
|
2001 S Shields St Ste J1, Fort Collins, CO 80526-1837 | |
| (970) 206-0100 | |
| (970) 206-0300 |
| Full Name | Jennifer Havrilla Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 2001 S Shields St Ste J1, Fort Collins, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114484656 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Margaret E Rado |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1639158231 PECOS PAC ID: 1658334065 Enrollment ID: I20041108000058 |
News Archive
UN officials are saying that their goal of containing the AIDS pandemic by 2015 may now be unrealistic because the spread of the disease is outpacing the efforts of many countries to prevent it.
Using immunotherapy biologic agents that stimulate the body's immune system pediatric oncologists have achieved the first substantial increase in over a decade in cure rates for the childhood cancer neuroblastoma. A newly released study shows that the new treatment improved two-year survival rates by 20 percent, compared to standard treatment for an aggressive form of neuroblastoma, a cancer of the nervous system.
A new literature review finds evidence that patients with chronic neck pain enrolled in clinical trials reported significant improvement following chiropractic spinal manipulation, according to a March/April 2007 report in the Journal of Manipulative and Physiological Therapeutics (JMPT).
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of Allowance from the United States Patent and Trademark Office covering technology relating to monoclonal antibodies that bind to certain epitopes present on pancreatic cancers. This patent will broaden the Company's proprietary intellectual property for ICT-109 and ICT-37, two of the Company's monoclonal antibody product candidates.
In a study published in Psycho-Oncology , excess weight was linked with poorer psychosocial health among older adults diagnosed with breast cancer or prostate cancer. The association was not seen in older patients with colon cancer, however.
› Verified 3 days ago
| Provider Name | Sara S Heffler |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1083639413 PECOS PAC ID: 7012033186 Enrollment ID: I20100927000192 |
News Archive
UN officials are saying that their goal of containing the AIDS pandemic by 2015 may now be unrealistic because the spread of the disease is outpacing the efforts of many countries to prevent it.
Using immunotherapy biologic agents that stimulate the body's immune system pediatric oncologists have achieved the first substantial increase in over a decade in cure rates for the childhood cancer neuroblastoma. A newly released study shows that the new treatment improved two-year survival rates by 20 percent, compared to standard treatment for an aggressive form of neuroblastoma, a cancer of the nervous system.
A new literature review finds evidence that patients with chronic neck pain enrolled in clinical trials reported significant improvement following chiropractic spinal manipulation, according to a March/April 2007 report in the Journal of Manipulative and Physiological Therapeutics (JMPT).
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of Allowance from the United States Patent and Trademark Office covering technology relating to monoclonal antibodies that bind to certain epitopes present on pancreatic cancers. This patent will broaden the Company's proprietary intellectual property for ICT-109 and ICT-37, two of the Company's monoclonal antibody product candidates.
In a study published in Psycho-Oncology , excess weight was linked with poorer psychosocial health among older adults diagnosed with breast cancer or prostate cancer. The association was not seen in older patients with colon cancer, however.
› Verified 3 days ago
| Provider Name | Jennifer A Havrilla |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1134480973 PECOS PAC ID: 3274783733 Enrollment ID: I20121019000128 |
News Archive
UN officials are saying that their goal of containing the AIDS pandemic by 2015 may now be unrealistic because the spread of the disease is outpacing the efforts of many countries to prevent it.
Using immunotherapy biologic agents that stimulate the body's immune system pediatric oncologists have achieved the first substantial increase in over a decade in cure rates for the childhood cancer neuroblastoma. A newly released study shows that the new treatment improved two-year survival rates by 20 percent, compared to standard treatment for an aggressive form of neuroblastoma, a cancer of the nervous system.
A new literature review finds evidence that patients with chronic neck pain enrolled in clinical trials reported significant improvement following chiropractic spinal manipulation, according to a March/April 2007 report in the Journal of Manipulative and Physiological Therapeutics (JMPT).
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of Allowance from the United States Patent and Trademark Office covering technology relating to monoclonal antibodies that bind to certain epitopes present on pancreatic cancers. This patent will broaden the Company's proprietary intellectual property for ICT-109 and ICT-37, two of the Company's monoclonal antibody product candidates.
In a study published in Psycho-Oncology , excess weight was linked with poorer psychosocial health among older adults diagnosed with breast cancer or prostate cancer. The association was not seen in older patients with colon cancer, however.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Havrilla Llc 2001 S Shields St Ste J1, Fort Collins, CO 80526-1837 Ph: (970) 206-0100 | Jennifer Havrilla Llc 2001 S Shields St Ste J1, Fort Collins, CO 80526-1837 Ph: (970) 206-0100 |
News Archive
UN officials are saying that their goal of containing the AIDS pandemic by 2015 may now be unrealistic because the spread of the disease is outpacing the efforts of many countries to prevent it.
Using immunotherapy biologic agents that stimulate the body's immune system pediatric oncologists have achieved the first substantial increase in over a decade in cure rates for the childhood cancer neuroblastoma. A newly released study shows that the new treatment improved two-year survival rates by 20 percent, compared to standard treatment for an aggressive form of neuroblastoma, a cancer of the nervous system.
A new literature review finds evidence that patients with chronic neck pain enrolled in clinical trials reported significant improvement following chiropractic spinal manipulation, according to a March/April 2007 report in the Journal of Manipulative and Physiological Therapeutics (JMPT).
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of Allowance from the United States Patent and Trademark Office covering technology relating to monoclonal antibodies that bind to certain epitopes present on pancreatic cancers. This patent will broaden the Company's proprietary intellectual property for ICT-109 and ICT-37, two of the Company's monoclonal antibody product candidates.
In a study published in Psycho-Oncology , excess weight was linked with poorer psychosocial health among older adults diagnosed with breast cancer or prostate cancer. The association was not seen in older patients with colon cancer, however.
› Verified 3 days ago
Lisa M Schneider, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 702 W Drake Rd Bldg B, Fort Collins, CO 80526 Phone: 970-221-4811 | |
Virginia Vision Care Assoc., L.l.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 102 W Mountain Ave, Fort Collins, CO 80524 Phone: 970-407-0665 | |
Ensight Skills Center, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 1101 Oakridge Dr Unit C, Fort Collins, CO 80525 Phone: 970-407-9999 Fax: 970-207-9844 | |
Dr. Jesica Mali Siriwardane, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2720 Council Tree Ave Ste 148, Fort Collins, CO 80525 Phone: 970-530-3097 | |
Dr. Mark D Jackson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1250 E Magnolia St, Fort Collins, CO 80524 Phone: 970-224-0606 Fax: 970-493-9309 | |
Dr. Sean M Mahaney, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1725 E Prospect Rd, Fort Collins, CO 80525 Phone: 970-221-2222 | |
Edge Optics Llc Optometrist Medicare: Medicare Enrolled Practice Location: 706 S College Ave, Suite 101, Fort Collins, CO 80524 Phone: 970-682-2627 |